Thoracic Oncology

If you've been diagnosed with a cancer of the chest, including lung cancer, it’s important to be evaluated by experts that focus on these cancers before beginning treatment. We can help.

Karmanos thoracic oncologists are among the best in the world. Team members are national leaders in chest malignancies and recognized experts in the treatment of thoracic cancers among national cooperative groups. The team has been involved in the development of recently approved novel drugs for the treatment of chest cancers and continues to be involved in clinical trials evaluating novel drugs.

Our team devotes time to research investigations including screening and early detection of lung cancer and mesothelioma, detection and treatment intervention in precancerous cells from the sputum of smokers, combined treatments for locally advanced cancers of the chest, clinical trials of combined chemotherapy and radiation therapy, radiation therapy approaches such as intensive modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), gamma knife radiation therapy for brain metastases and studies of novel targeted drugs. They also collaborate with our Phase I Clinical Trials Program.

Additionally, the MONARCH® Robotic Assisted Bronchoscopy Platform gives Karmanos physicians a greater reach, enhanced vision and better control when performing lung biopsies. This technology aims to help physicians overcome the challenges they face when biopsying small, peripheral lung nodules. The MONARCH® Platform’s technology combines the latest advancements in robotic control, small instruments, endoscope design, vision and data science into one platform. For the first time, physicians have both direct vision and software to guide the scope to the small mass.

Do have questions or concerns about lung cancer?

  • What are the symptoms and risk factors to be aware of?
  • How do you detect or screen for lung cancer?
  • What are the treatment options?

Evaluation & Diagnosis

Each patient receives personal attention from the Thoracic Oncology Multidisciplinary Team. During your initial visit, all the physicians of the team necessary for your case will review your medical records and medical history, x-rays and pathology slides. The team meets regularly to discuss patient care issues and refine individual patient treatment plans. 

Innovative, Individualized Care

Our team devotes time to research investigations to improve treatment options and early prevention measures for individuals with thoracic malignancies. 

Here’s what patients can expect from our Thoracic Oncology Multidisciplinary Team:

  • A passionate, caring, expert team of doctors whose only focus is chest cancers, giving you the best chance of success.
  • A collaborative approach that considers all available treatment options, including latest surgical and clinical trials, for your specific type of cancer.
  • A carefully constructed treatment plan designed to achieve the best possible outcome.
  • Respectful, compassionate care that is responsive to your emotional needs and lifestyle.
  • Proactive, timely communication with you and your loved ones, and your personal physician.

Appointment Information

Request an Appointment Online Request an Appointment By Phone

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Detroit Cancer Center Unveils New Device for Treating Liver Cancer at Home

The Detroit News The TheraBionic P1 device is now available for patients who have advanced liver cancer and have failed first- and second-line the...

Read More

Karmanos Cancer Institute Physicians Begin Prescribing New FDA-approved Radiofrequency Electromagnetic Device to Treat Advanced Liver Cancer

The Barbara Ann Karmanos Cancer Institute , the largest provider of cancer care and research in Michigan and part of McLaren Health Care, announce...

Read More

CURE, in Collaboration with Karmanos' Office of Cancer Health Equity and Community Engagement, Educates the Community About Metastatic Breast Cancer

On Wednesday, Dec. 4, 2024, patients, survivors, and advocates gathered at Karmanos Cancer Institute in Detroit to learn about metastatic breast c...

Read More
News

WDET | Scholarship Program Aims to Encourage More Diversity in Clinical Trials

Listen Now

101 WRIF | Lung Cancer Awareness

Listen Now

Becker’s Healthcare Podcast | Exploring Breakthroughs in Cancer Treatment with Dr. Boris C. Pasche, President & CEO at Karmanos Cancer Institute

Listen Now